SRI-8858

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameSRI-8858
Drug Alias NameSRI-8858
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDihydrofolate reductase inhibitors
TargetsDihydrofolate reductase
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSouthern Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSouthern Research Institute
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A